Yes, there is a massive consumer market with an affluent middle class on our very doorstep, which should develop more over time. The ABC The Business segment shows the massive untapped potential to be unlocked over time.
Together with its re-entry into beer, CCL is pursuing smart growth opportunities to underpin its earnings over time and it will be a very different company in 5-10 years.
Sounds like one for the bottom drawer at these prices.
The p/e of 17 is not necessarily a concern in my view. I don't think prospective buyers should overlook what the above growth initiatives are contributing to the p/e. The p/e is not that much higher than the major banks any way - WBC for example has a p/e of 14.44. CCL has an iconic brand and monopolistic characteristics (similar to major banks), as referred to below.
ETrade's research says - Coca-Cola Amatil is the dominant player in Australia and other regional markets, with strong brand recognition and excellent distribution networks. We consider the firm's narrow economic moat intact. While the Australian market is mature, substantial investment and strong economic growth in Indonesia could provide material upside over the longer term while alcoholic beverages give mild blue sky.
- Forums
- ASX - By Stock
- CCL
- all aboard!!!!
CCL
cuscal limited
Add to My Watchlist
0.32%
!
$3.10

all aboard!!!!, page-4
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$3.10 |
Change
-0.010(0.32%) |
Mkt cap ! $593.8M |
Open | High | Low | Value | Volume |
$3.15 | $3.15 | $3.02 | $1.083M | 349.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2000 | $3.04 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.14 | 9599 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 400 | 3.020 |
1 | 5000 | 3.000 |
1 | 1700 | 2.990 |
1 | 8500 | 2.970 |
2 | 1858 | 2.960 |
Price($) | Vol. | No. |
---|---|---|
3.150 | 20000 | 1 |
3.380 | 15000 | 1 |
3.600 | 4000 | 1 |
3.800 | 100 | 1 |
0.000 | 0 | 0 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
CCL (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online